🇺🇸 Amlodipine 10 in United States

134 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dizziness — 17 reports (12.69%)
  2. Dyspnoea — 16 reports (11.94%)
  3. Fatigue — 16 reports (11.94%)
  4. Headache — 16 reports (11.94%)
  5. Hypotension — 14 reports (10.45%)
  6. Hypertension — 13 reports (9.7%)
  7. Acute Kidney Injury — 11 reports (8.21%)
  8. Nausea — 11 reports (8.21%)
  9. Arthralgia — 10 reports (7.46%)
  10. Chest Pain — 10 reports (7.46%)

Source database →

Amlodipine 10 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Amlodipine 10 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Amlodipine 10 in United States?

Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.